---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-047180"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T05:55:44.826293+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Virpax realigns board classes: Ruskin moves to Class I; quorum cut to 34%

## Summary
- Director Barbara Ruskin resigned from Class III and was appointed to Class I, effective June 5, 2023.
- Her term now extends to the 2025 annual meeting (previously 2024).
- Bylaws amended to reduce quorum requirement to 34% of voting power at stockholder meetings.

## SEC filing metadata
- accession: 0001213900-23-047180
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000121390023047180/0001213900-23-047180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000121390023047180/ea179780-8k_virpaxpharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-047180
- JSON: https://secwatch.observer/filing/0001213900-23-047180.json
- Plain text: https://secwatch.observer/filing/0001213900-23-047180.txt

## Key facts
- Governance Changes
  Virpax Pharmaceuticals, Inc.: Amended quorum requirement to 34% voting power of shares issued and entitled to vote (effective 2023-06-05).
  - Change: bylaw amendment
  - Effective: 2023-06-05
  source text: On June 5, 2023, the Company’s Board of Directors amended the Company’s by-laws, effective immediately in order to amend the quorum requirement of ninth paragraph of Article I, Section 1.6 of the by-laws, such that thirty-four percent (34%) in voting power of shares of the capital stock of the Company issued and entitled to vote at the meeting, present in person or present by means of remote communication in a manner, if any , shall constitute a quorum for the transaction of business at all meetings of the stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000121390023047180/0001213900-23-047180-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.